Delhi High Court stops Dr. Reddy’s from selling Ozempic-like drug after Novo Nordisk claims patent infringement. The case now awaits a detailed hearing in August 2025.
![[InterDigital Patent Infringement Case] Delhi HC Rejected Plea of Access License Agreements of Oppo, RealMe And OnePlus](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/06/MicrosoftTeams-image-64.png?resize=447%2C367&ssl=1)
The Delhi High Court denied InterDigital Technology’s request to access licensing agreements between Oppo, RealMe, and OnePlus and two Standard Essential Patent licensors. Both sides were directed to submit certain licensing agreements with chipset supplier Qualcomm. The main suit will be heard on July 3, with a decision expected by the end of 2024.
The Delhi High Court has ordered LAVA to compensate Ericsson with over Rs. 244 crore for infringing on its 2G and 3G technology patents. The judgment emphasizes the significance of fair licensing terms for Standard Essential Patents (SEPs), setting a precedent for the ongoing discourse on SEPs and the need for FRAND terms. Justice Bansal’s comprehensive 476-page judgment affirmed the critical nature of these patents in mobile communication and highlighted the impracticality of licensing individual patents from a portfolio. The court’s commitment to ensuring rightful compensation for patent owners and promoting economic efficiency is underscored, reflecting on the broader implications for innovation and standardization in the telecommunications industry.
